Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/05/033868
CTRI/2021/05/033868
Not yet recruiting
Phase 2

ow dose radiotherapy to bilateral lungs for COVID-19 pneumonia - A Prospective Single Centre Study

Kolhapur Cancer Centre0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Kolhapur Cancer Centre
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Kolhapur Cancer Centre

Eligibility Criteria

Inclusion Criteria

  • •Patients with RT\-PCR proven COVID\-19 infection with moderate to severe pneumonia with National Early Warning Score \[NEWS] 5 or more.

Exclusion Criteria

  • •1\.Patients requiring mechanical ventilation
  • •2\.Prior lobectomy or pneumonectomy
  • •3\.Prior thoracic radiotherapy
  • •4\.Prior chemotherapy or other systemic therapy with potential for pulmonary toxicity
  • •5\.Prior radio\-sensatization
  • •6\.Severe pre\-existing heart disease e.g. New York Heart Association \[NYHA] functional class 3 or higher, congestive cardiac failure
  • •7\.History of Bone marrow or solid organ transplant
  • •8\.Known history of autoimmune collagen vascular disease
  • •9\.Known hereditory syndrome with increased sensitivity to ionizing radiation e.g. ataxia\-telengiectasia or Fanconi anemia
  • •10\.Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
ow Dose Radiotherapy for COVID-19 Pneumonia using a Linear acceleratorHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2021/06/033911Guru Hospitals
Not yet recruiting
Phase 2
ow dose Radiotherapy for COVID-19 using Linear accelerator
CTRI/2021/05/033883Surya Global Multi Speciality Hospital
Recruiting
Phase 1
ow Dose Radiation Therapy for COVID-19
CTRI/2020/06/025862ot yet applied for funding
Active, not recruiting
Not Applicable
Dose radiotherapy for lung cancer treatment.ung cancer.Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2010-021382-78-ESConsorci Mar Parc de Salut de Barcelona (Parc de Salut MAR)
Completed
Phase 2
Phase II study of thoracic radiotherapy concurrently combined with cisplatin and vinorelbine chemotherapy followed by sequential therapy with TS-1 for inoperable locally advanced non-small cell lung cancer
JPRN-UMIN000002381ational Hospital Study Group for Lung Cancer65